Genetic and Phenotypic Characterization of the Novel Metallo-β-Lactamase NDM-29 From Escherichia coli

Objectives: The New Delhi metallo-β-lactamase (NDM) can hydrolyze almost all clinically available β-lactam antibiotics and has widely spread all over the world. NDM-29, a novel carbapenemase, was discovered in an Escherichia coli (19NC225) isolated from a patient with biliary tract infection in 2019...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ying Zhu, Xinmiao Jia, Peiyao Jia, Xue Li, Qiwen Yang
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
NDM
Acceso en línea:https://doaj.org/article/6f122d64b2b54b748b5e178958e10333
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6f122d64b2b54b748b5e178958e10333
record_format dspace
spelling oai:doaj.org-article:6f122d64b2b54b748b5e178958e103332021-11-10T11:21:45ZGenetic and Phenotypic Characterization of the Novel Metallo-β-Lactamase NDM-29 From Escherichia coli1664-302X10.3389/fmicb.2021.743981https://doaj.org/article/6f122d64b2b54b748b5e178958e103332021-09-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fmicb.2021.743981/fullhttps://doaj.org/toc/1664-302XObjectives: The New Delhi metallo-β-lactamase (NDM) can hydrolyze almost all clinically available β-lactam antibiotics and has widely spread all over the world. NDM-29, a novel carbapenemase, was discovered in an Escherichia coli (19NC225) isolated from a patient with biliary tract infection in 2019 in China.Methods: Conjugation, transformation, cloning test, fitness cost, PacBio Sequel, and Illumina sequencing were performed to analyze the genetic and phenotypic characterization of blaNDM–29.Results: The susceptibility testing results showed 19NC225 was resistant to cephalosporins, carbapenems, combinations of β-lactam and β-lactamase inhibitors, and levofloxacin. Conjugation and transformation were performed to verify the transferability of NDM-29-encoding plasmid, and cloning test was conducted to prove the function of blaNDM–29 to increase carbapenem resistance. Furthermore, fitness cost test confirmed that the presence of NDM-29 exerts no survival pressure on bacteria. PacBio Sequel and Illumina sequencing were performed to analyze the genetic characterization of 19NC225, which contains two plasmids (pNC225-TEM1B and pNC225-NDM-29). pNC225-NDM-29, exhibiting 99.96% identity and 100% coverage with pNDM-BTR (an IncN1 plasmid from an E. coli in urine specimen from Beijing in 2013), showed responsibility for the multidrug-resistant (MDR) phenotype. Compared with blaNDM–1, blaNDM–29, located on pNC225-NDM-29, carries a G388A (D130N) mutation. The region harboring blaNDM–29 is located in an ISKpn19-based transposon, and two Tn6292 remnants are symmetrically located upstream and downstream of the transposon. The sequence results also indicated several important virulence genes.Conclusion: The findings of the novel carbapenemase NDM-29 could pose a threat to the control of antimicrobial resistance and arouse attention about the mutation of bacteria.Ying ZhuYing ZhuXinmiao JiaXinmiao JiaPeiyao JiaPeiyao JiaXue LiXue LiQiwen YangFrontiers Media S.A.articlecarbapenemaseNDMEscherichia coliwhole-genome sequenceantimicrobial resistanceMicrobiologyQR1-502ENFrontiers in Microbiology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic carbapenemase
NDM
Escherichia coli
whole-genome sequence
antimicrobial resistance
Microbiology
QR1-502
spellingShingle carbapenemase
NDM
Escherichia coli
whole-genome sequence
antimicrobial resistance
Microbiology
QR1-502
Ying Zhu
Ying Zhu
Xinmiao Jia
Xinmiao Jia
Peiyao Jia
Peiyao Jia
Xue Li
Xue Li
Qiwen Yang
Genetic and Phenotypic Characterization of the Novel Metallo-β-Lactamase NDM-29 From Escherichia coli
description Objectives: The New Delhi metallo-β-lactamase (NDM) can hydrolyze almost all clinically available β-lactam antibiotics and has widely spread all over the world. NDM-29, a novel carbapenemase, was discovered in an Escherichia coli (19NC225) isolated from a patient with biliary tract infection in 2019 in China.Methods: Conjugation, transformation, cloning test, fitness cost, PacBio Sequel, and Illumina sequencing were performed to analyze the genetic and phenotypic characterization of blaNDM–29.Results: The susceptibility testing results showed 19NC225 was resistant to cephalosporins, carbapenems, combinations of β-lactam and β-lactamase inhibitors, and levofloxacin. Conjugation and transformation were performed to verify the transferability of NDM-29-encoding plasmid, and cloning test was conducted to prove the function of blaNDM–29 to increase carbapenem resistance. Furthermore, fitness cost test confirmed that the presence of NDM-29 exerts no survival pressure on bacteria. PacBio Sequel and Illumina sequencing were performed to analyze the genetic characterization of 19NC225, which contains two plasmids (pNC225-TEM1B and pNC225-NDM-29). pNC225-NDM-29, exhibiting 99.96% identity and 100% coverage with pNDM-BTR (an IncN1 plasmid from an E. coli in urine specimen from Beijing in 2013), showed responsibility for the multidrug-resistant (MDR) phenotype. Compared with blaNDM–1, blaNDM–29, located on pNC225-NDM-29, carries a G388A (D130N) mutation. The region harboring blaNDM–29 is located in an ISKpn19-based transposon, and two Tn6292 remnants are symmetrically located upstream and downstream of the transposon. The sequence results also indicated several important virulence genes.Conclusion: The findings of the novel carbapenemase NDM-29 could pose a threat to the control of antimicrobial resistance and arouse attention about the mutation of bacteria.
format article
author Ying Zhu
Ying Zhu
Xinmiao Jia
Xinmiao Jia
Peiyao Jia
Peiyao Jia
Xue Li
Xue Li
Qiwen Yang
author_facet Ying Zhu
Ying Zhu
Xinmiao Jia
Xinmiao Jia
Peiyao Jia
Peiyao Jia
Xue Li
Xue Li
Qiwen Yang
author_sort Ying Zhu
title Genetic and Phenotypic Characterization of the Novel Metallo-β-Lactamase NDM-29 From Escherichia coli
title_short Genetic and Phenotypic Characterization of the Novel Metallo-β-Lactamase NDM-29 From Escherichia coli
title_full Genetic and Phenotypic Characterization of the Novel Metallo-β-Lactamase NDM-29 From Escherichia coli
title_fullStr Genetic and Phenotypic Characterization of the Novel Metallo-β-Lactamase NDM-29 From Escherichia coli
title_full_unstemmed Genetic and Phenotypic Characterization of the Novel Metallo-β-Lactamase NDM-29 From Escherichia coli
title_sort genetic and phenotypic characterization of the novel metallo-β-lactamase ndm-29 from escherichia coli
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/6f122d64b2b54b748b5e178958e10333
work_keys_str_mv AT yingzhu geneticandphenotypiccharacterizationofthenovelmetalloblactamasendm29fromescherichiacoli
AT yingzhu geneticandphenotypiccharacterizationofthenovelmetalloblactamasendm29fromescherichiacoli
AT xinmiaojia geneticandphenotypiccharacterizationofthenovelmetalloblactamasendm29fromescherichiacoli
AT xinmiaojia geneticandphenotypiccharacterizationofthenovelmetalloblactamasendm29fromescherichiacoli
AT peiyaojia geneticandphenotypiccharacterizationofthenovelmetalloblactamasendm29fromescherichiacoli
AT peiyaojia geneticandphenotypiccharacterizationofthenovelmetalloblactamasendm29fromescherichiacoli
AT xueli geneticandphenotypiccharacterizationofthenovelmetalloblactamasendm29fromescherichiacoli
AT xueli geneticandphenotypiccharacterizationofthenovelmetalloblactamasendm29fromescherichiacoli
AT qiwenyang geneticandphenotypiccharacterizationofthenovelmetalloblactamasendm29fromescherichiacoli
_version_ 1718439999647514624